comparemela.com
  1. Home
  2. Live Updates
  3. aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD : comparemela.com

aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD

aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States ,Ashlee Dunston ,Sanjays Shukla ,Public Affairs ,European Union ,Rheumatic Lung Disease Program ,Drug Administration ,Atyr Pharma Inc ,Nasdaq ,Tyr Pharma ,Chief Executive Officer ,Kristin Highland ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Report ,Investor Relations ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.